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Which articles get published and why? 
I am often asked: ‘which articles get published in JAN?’ or ‘what kind of articles are you 
looking for?’ and I find both questions hard to answer. My honest answer to the first question 
is: ‘those articles that survive the review process and are then accepted by the editors’ and to 
the second question: ‘those articles that will meet the criteria in the previous answer.’ I think 
I know why people ask and it is not merely out of curiosity. They want to see if they can have 
a shortcut to getting published; if they only knew what got published…they’d write it! 
I think this is the wrong way to approach the problem of getting published, and with an 80% 
rejection rate at JAN, there is clearly a problem for approximately 1000 of the people who 
submit to JAN annually. The better question, however, and one I do get asked occasionally is: 
‘what can I do to make my article more likely to be published?’ Again, I don’t have an 
immediate or simple answer, but these people are at least thinking what they can do with their 
work and their manuscripts to make them more attractive to editors and reviewers. 
Nevertheless, I thought it was worth giving the issue of what gets published in JAN some 
consideration. 
Initial screening 
As Editor-in-Chief, I am the first person to see manuscripts after they are submitted. Some 
authors are surprised at the speed with which they have a verdict of reject on their manuscript; 
sometimes within minutes after submission. If I happen to be logged into the ScholarOne 
platform then, as soon as an author submits, I am alerted to the submission. In most cases, it 
only takes me a few minutes to decide if a manuscript is going forward to the Managing Editor 
or is being returned to the authors and it is only those manuscripts going forward that have any 
chance, but no guarantee, of being published. They may not survive the reviewers and the 
editors to whom they are allocated. I think many authors will be surprised that the decisions 
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made at this initial filtering stage are not as ‘high-level’ or intellectual as they assume. Editors-
in-Chief are relatively simple people, most have full-time academic jobs and an increasing 
number of manuscripts to process. Decisions must be made based on whether or not a 
manuscript is likely to meet the requirements of the reviewers and editors and if it does, is it an 
article that is likely to be read and cited. Be under no illusion, all Editors-in-Chief are looking 
for citeable articles; publishing articles that have no measurable impact on the field is futile. 
Therefore, I have listed a series of considerations that I apply to submitted articles. This is 
neither a formula nor a guarantee of eventual publication and nor do I claim that I make the 
right decision in every case. We continue to publish articles that never get cited and I am sure 
I reject some that go on the be accepted and highly cited elsewhere. Our only indication that 
we are getting something right is the annual increase in citations to JAN articles which is also 
reflected in our steadily increasing impact factor. 
 
Fit 
Fundamentally, the articles which get published in JAN are those which ‘fit’ the journal. The 
concept of fit is not easy to articulate but, clearly, it is obvious to me when an article does not 
fit JAN. For example, the article may not in any way be related to nursing. It may be close, 
for example, a clinical trial of a drug. The latter would not fit, according to our present 
criteria, as this is within the domains of medicine and pharmacology and will fit much better 
and medical or a pharmacological journal. It should be relatively easy for a prospective 
author to gauge whether a manuscript is likely to fit JAN by: 1) checking our Aims and 
Scope; and 2) browsing the contents lists of a few recent volumes. Admittedly, manuscripts 
which really do not fit the journal are rarely submitted and this does not seem to be a major 
obstacle for authors. The problems arise for authors of—and most decisions must be made by 
me regarding—manuscripts which do fit JAN, but which may then be unsuitable for other 
reasons. 
Title 
It helps greatly if the title is short and accurate. We specify 20 words maximum for a title, but 
many authors ignore this. The title should be no more than two lines on a printed page and 
should tell the Editor-in-Chief—and, ultimately, the reader—what the study is about and, for 
certain studies, how it was done. Therefore, consider your title carefully, edit it to have as few 
words as possible and to convey exactly what you did. It is best to avoid questions in the title 
and it is also best to avoid saying what was found. The types of study where it is advisable to 
include the design are systematic reviews and clinical trials. 
Being international we like our articles to be as widely applicable, globally, as possible and 
for that reason, we prefer not to see the country where the study was carried out mentioned in 
the title. Sometimes this can be addressed by editing the title but sometimes it indicates a 
study which is only locally or nationally applicable. However, if a manuscript is reporting a 
national survey then, depending on the size and scope, this could be a reason for indicating 
the country in the title, but the title should also indicate that the study is national. 
I also strongly advocate that you do not ‘shoot yourself in the foot’ with the title of your 
manuscript. Examples of how people do this—in addition to including the country in the 
title—are to include words like: ‘small’; ‘local’; and ‘preliminary’. If a study is good it does 
not matter where it is done or how restricted it is geographically, provided you make the 
importance of the study clear to an international audience. Of course, you cannot 
misrepresent your work, but you should not apologise for it either. If you use a word such as 
‘preliminary’ then what do you mean by this? If it is a polit study, then it should be described 
as such and written according to our guidelines for pilot studies. If it is feasibility study, then 
describe it as such. Otherwise, if you have carried out a good study that you consider is worth 




A manuscript submitted to JAN with the abstract in the wrong format is likely to be rejected. 
This is a clear indication that the authors have not read our guidelines and have not checked a 
typical JAN article online or are simply recycling a manuscript that has been rejected by 
another journal. This is such an easy step the take as we make plenty of our copy free to 
access online. My view is that if you cannot be bothered to do this then we do not have time 
to process your manuscript. I take a similarly dim view of manuscripts with the Vancouver 
referencing system; we use Harvard. 
 
Acceptable type 
One common reason for rejecting articles at this early stage is their unacceptability according 
to the current JAN guidelines, and these are updated at least annually. For example, a 
manuscript may appear to fall within the scope of the journal, but the specific type of study 
may no longer be acceptable. At the time of writing, those articles which we consider 
unacceptable are: translations and revalidations of questionnaires; concept analyses; and 
discussion papers. Whilst implicit, but not explicit in our guidelines, we are also not very 
interested in articles which measure nurses’ or nursing students’ attitudes or opinions. We do 
not accept narrative reviews which have no systematic element, and we do not accept studies 
arising from service evaluations or clinical audits, especially where no ethical permission has 
been obtained to use the data for research and publication. 
EQUATOR and All Trails compliance 
Our guidelines clearly state that, where possible, appropriate EQUATOR guidelines should 
be followed when preparing manuscripts. The most common of these are the CONSORT and 
PRISMA checklists for clinical trials and systematic reviews, respectively. In addition, for all 
intervention studies—not only randomised controlled trials—we expect the study to be 
registered appropriately. These are remarkable easy things for me to check and, if I am in any 
doubt, for the managing editor to check; they are frequently omitted. This immediately 
suggests that the authors have not read our guidelines and casts a very unfavourable light 
over the manuscript; greatly increasing its chances of being rejected. 
 
Some other considerations 
Beyond what I outline above, it is hard to be more specific, but it is never attractive to see the 
blindingly obvious being restated. Another correlative study on the impact of Diabetes on 
adolescent mental health or a qualitative study of the impact of stroke on sexual function may 
well be publishable and contribute to knowledge. However, that contribution will be small 
given the number of such studies and cannot be a priority for JAN. Replication is laudable in 
research, but it needs to be justified, for example due to methodological weakness or 
heterogeneity in previous studies. Simply adding ‘in [country]’ is not adequate justification. 
I sincerely hope that this editorial has been useful in helping you know to make your 
manuscript more suitable for submission to JAN or even dissuaded you from submitting if 
your manuscript is not suitable. On the other hand, 20% of the manuscripts submitted to JAN 
do get published. Your challenge is to be in that 20% and my challenge is to ensure that I 
select the best. 
Roger Watson 
Editor-in-Chief, JAN 
